SELECT
» Drugs in development
» Biotechnology facts and figures
» Key Technologies
DISEASES
» Anemia (2005)
» Breast Cancer (2007)
» Cardiovascular Diseases (2007)
» Diabetes (2005)
» Growth Hormone Deficiency (2005)
» Haemophilia (2005)
» Hepatitis B (2005)
» Inflammatory Bowel Disease (2007)
» Lymphomas (2005)
» Multiple Sclerosis (2005)
» Rheumatoid Arthritis and other Inflammatory Rheumatism (2007)
About BioImpact
<div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"><span style="font-weight: bold; font-size: 13px; color: rgb(0,153,255); font-family: Arial,Helvetica,sans-serif; text-align: left">Objective of BioImpact.org</span></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff" /></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><font color="#33ccff"><strong><font style="background-color: rgb(255,255,255)"></font></strong></font></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif">The BioImpact project aims to <strong>raise awareness of the current value and importance of biotechnologies for public health</strong>. It is important to be able to access the latest scientific data available in order to understand the relevance and benefits of these medicines. </font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif">BioImpact gives a solid image of the contribution that biotechnologies have made to therapeutic progress and public health, by highlighting the major advances made in these technologies, both in diagnosis and medical treatments. In the long term, BioImpact will draw up an inventory of therapeutic products with high added value and the positive effects that they have on biotechnologies in terms of improvement of public health. <br /> <br /> Medicines developed from biotechnologies are defined in this study as medicines developed using life sciences techniques, whose production requires living organisms or their cellular components (OCDE definition)<br /> <br /> <strong><font color="#33ccff"><span style="font-weight: bold; font-size: 13px; color: rgb(0,153,255); font-family: Arial,Helvetica,sans-serif; text-align: left">General methodology</span></font></strong></font></font></div> <div align="justify"><font size="2"><font face="Arial, Helvetica, sans-serif"><br /> The monographs presented summarize the best scientific data currently available on the causes and characteristics of each pathology, its associated complications (clinical data), the number of patients affected and the change in the number of patients over time, the death rate (epidemiological data), and compares traditional treatments with biotechnological treatments available, especially in terms of efficiency (pharmacological data, clinical data). Where available, data relating to cost-effectiveness of medicines are also reported. <br /> <br /> The study reports on the positive (and negative) effects of major medicines developed through biotechnologies in terms of their effectiveness (impact on quality of life and life expectancy, treatment of diseases that up to now remained without a therapeutic treatment, early or preventive diagnosis…), their safety (impact on the reduction of pathologies associated with previously used treatments) and their impact on health costs. <br /> <br /> All data were reviewed by the specialists in pathologies concerned and also by a pluri-disciplinary and independent <strong>Steering Committee </strong>made up of clinicians, epidemiologists, pharmacologists and pharmo-economists, to provide the most complete and objective information possible. <br /> Furthermore, with the aim of making this sometimes highly technical information available to the greatest number of people, BioImpact offers several levels of readership, from the introductory document to the most comprehensive bibliographical references.</font></font></div> <p><span style="font-weight: bold; font-size: 13px; color: #0099ff; font-family: Arial, Helvetica, sans-serif; text-align: left" /></p> <p align="justify">Author and reviewers</p> <p><span style="font-weight: normal; font-size: 12px; color: #000000; font-family: Arial, Helvetica, sans-serif; text-align: justify" /></p> <p align="justify">BioImpact.org is a study prepared by <strong>Dr. Philippe Cramer</strong>, pediatrician and entrepreneur, and reviewed by several clinical and academic experts of each disease:</p> <div align="justify"> <ul> <li>Breast Cancer: <em>Pr. Michel Marty, PU-PH, Hôpital St Louis</em></li> <li>Cardiovascular diseases: <em>Pr. Alain Castaigne, Hôpital Henri Mondor</em></li> <li>Inflammatory Bowel diseases: <em>Dr. Matthieu Allez, Hôpital St Louis</em></li> <li>Rheumatoid Arthritis: <em>Dr.Géraldine Falgarone, CHU Avicenne</em></li> </ul> </div> <p> </p>
